Evidence map›Paper›PMID 36744541›Full record

ArticleThe Journal of physiology2023

Diversity of cells and signals in the cardiovascular system.

Eleonora Grandi, Manuel F Navedo, Jeffrey J Saucerman, Donald M Bers, Nipavan Chiamvimonvat, Rose E Dixon, Dobromir Dobrev, Ana M Gomez, Osama F Harraz, Bence Hegyi and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 4 countries.

Eleonora GrandiDepartment of Pharmacology, University of California Davis, Davis, CA, USA.ORCID 0000-0002-4401-8857
Manuel F NavedoDepartment of Pharmacology, University of California Davis, Davis, CA, USA.ORCID 0000-0001-6864-6594
Jeffrey J SaucermanDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA.
Donald M BersDepartment of Pharmacology, University of California Davis, Davis, CA, USA.ORCID 0000-0002-2237-9483
Nipavan ChiamvimonvatDepartment of Pharmacology, University of California Davis, Davis, CA, USA.ORCID 0000-0001-9499-8817
Rose E DixonDepartment of Physiology and Membrane Biology, University of California Davis, Davis, CA, USA.ORCID 0000-0003-0655-690X
Dobromir DobrevInstitute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.ORCID 0000-0002-4612-117X
Ana M GomezSignaling and Cardiovascular Pathophysiology-UMR-S 1180, INSERM, Université Paris-Saclay, Orsay, France.
Osama F HarrazDepartment of Pharmacology, Larner College of Medicine, and Vermont Center for Cardiovascular and Brain Health, University of Vermont, Burlington, VT, USA.ORCID 0000-0003-2061-1100
Bence HegyiDepartment of Pharmacology, University of California Davis, Davis, CA, USA.ORCID 0000-0003-3113-221X
David K JonesDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA.
Trine Krogh-MadsenDepartment of Physiology & Biophysics, Weill Cornell Medicine, New York, NY, USA.
Walter Lee MurfeeJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, USA.ORCID 0000-0002-8247-4722
Matthew A NystoriakDepartment of Medicine, Division of Environmental Medicine, Center for Cardiometabolic Science, University of Louisville, Louisville, KY, USA.ORCID 0000-0001-8872-158X
Nikki G PosnackDepartment of Pediatrics, Department of Pharmacology and Physiology, The George Washington University, Washington, DC, USA.ORCID 0000-0002-3880-7200
Crystal M RipplingerDepartment of Pharmacology, University of California Davis, Davis, CA, USA.ORCID 0000-0002-9908-4106
Rengasayee VeeraraghavanDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH, USA.ORCID 0000-0002-8364-2222
Seth WeinbergDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH, USA.ORCID 0000-0003-1170-0419
University of California, Davis · USThe Ohio State University Wexner Medical Center · USBaylor College of Medicine · USChildren's National · USCornell University · USInserm · FRUniversity of Florida · USUniversity of Louisville · USUniversity of Michigan · USUniversity of Vermont · USUniversity of Virginia · US

Funding

Project 3 (Mercola)P01HL141084 · NHLBI · STANFORD UNIVERSITY · PI MARK MERCOLA · 2019 to 2026
$21.1M
Vermont Center for Cardiovascular and Brain HealthP20GM135007 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Diego Adrianzen Herrera · 2020 to 2026
$17.4M
Functional Interactions of Cardiac Ion ChannelsR01HL085844 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHIAMVIMONVAT, NIPAVAN · 2007 to 2025
$7.3M
The Role of Adrenergic Stimulation in ArrhythmogenesisR01HL111600 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Crystal May Ripplinger · 2012 to 2026
$7.1M
Ryanodine receptor regulation in post-operative atrial fibrillationR01HL089598 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2007 to 2022
$6.5M
Translational Study of Cardiac DysfunctionR01HL085727 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHIAMVIMONVAT, NIPAVAN, SIRISH, PADMINI · 2008 to 2022
$5.7M
Development of the Predictive NeuroCardiovascular SimulatorOT2OD026580 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CLANCY, COLLEEN E, GRANDI, ELEONORA · 2018 to 2021
$5.7M
The Role of Inflammasome in the Pathogenesis of Atrial FibrillationR01HL136389 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Na Li · 2017 to 2026
$5.6M
CaMKII activation and regulation in adult cardiac myocytesR01HL142282 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M, BOSSUYT, JULIE B · 2018 to 2025
$5.4M
Sex-specific arrhythmogenic mechanisms of atrial fibrillationR01HL131517 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Eleonora Grandi · 2016 to 2026
$5.0M
Coupling of Vascular Cav1.2 Channels In Health & DiseaseR01HL121059 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAVEDO, MANUEL F · 2015 to 2024
$4.5M
Functional Microdomains in the Heart's Pacemaker: A New Dimension of Cardiac RemodelingR01HL141214 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Alexey V Glukhov · 2018 to 2026
$3.8M
American Heart Association-American Stroke Association 20CDA35310097 - OSAMA HARRAZNHLBI NIH HHS P01 HL141084NHLBI NIH HHS R01 HL085727NHLBI NIH HHS R01 HL085844NHLBI NIH HHS R01 HL089598NHLBI NIH HHS R01 HL111600NHLBI NIH HHS R01 HL121059NHLBI NIH HHS R01 HL131517NHLBI NIH HHS R01 HL136389NHLBI NIH HHS R01 HL137228NHLBI NIH HHS R01 HL137755NHLBI NIH HHS R01 HL138003NHLBI NIH HHS R01 HL141214NHLBI NIH HHS R01 HL142282NHLBI NIH HHS R01 HL142710NHLBI NIH HHS R01 HL149127NHLBI NIH HHS R01 HL159304NHLBI NIH HHS R01 HL160665NHLBI NIH HHS R01 HL161872NHLBI NIH HHS R01 HL162825NHLBI NIH HHS R01 HL162925NHLBI NIH HHS R01 HL163277NHLBI NIH HHS R13 HL162430NHLBI NIH HHS R21 HL159501NHLBI NIH HHS U01 HL136297NIA NIH HHS R01 AG063796NICHD NIH HHS R01 HD108839NIGMS NIH HHS P20 GM135007NIH HHS OT2 OD026580
6 · The paper itself

Abstract

This white paper is the outcome of the seventh UC Davis Cardiovascular Research Symposium on Systems Approach to Understanding Cardiovascular Disease and Arrhythmia. This biannual meeting aims to bring together leading experts in subfields of cardiovascular biomedicine to focus on topics of importance to the field. The theme of the 2022 Symposium was 'Cell Diversity in the Cardiovascular System, cell-autonomous and cell-cell signalling'. Experts in the field contributed their experimental and mathematical modelling perspectives and discussed emerging questions, controversies, and challenges in examining cell and signal diversity, co-ordination and interrelationships involved in cardiovascular function. This paper originates from the topics of formal presentations and informal discussions from the Symposium, which aimed to develop a holistic view of how the multiple cell types in the cardiovascular system integrate to influence cardiovascular function, disease progression and therapeutic strategies. The first section describes the major cell types (e.g. cardiomyocytes, vascular smooth muscle and endothelial cells, fibroblasts, neurons, immune cells, etc.) and the signals involved in cardiovascular function. The second section emphasizes the complexity at the subcellular, cellular and system levels in the context of cardiovascular development, ageing and disease. Finally, the third section surveys the technological innovations that allow the interrogation of this diversity and advancing our understanding of the integrated cardiovascular function and dysfunction.

Indexed as

Cardiovascular DiseasesEndothelial CellsArrhythmias, CardiacHumansMyocytes, Cardiacanimal modelsion channelsion transportersmodellingomicssignal transduction

Identifiers

PMID36744541
PMCPMC10313794
OpenAlexW4319294890

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.